Company intelligence / Profile preview

Co-win Ventures

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Co-win Ventures is a leading Chinese venture capital firm founded in 2009 that specializes in angel and early-stage investments across TMT and healthcare sectors. It has invested in over 120 companies—more than half at the angel round—and has helped more than ten reach public markets. Its healthcare portfolio spans biopharmaceuticals (e.g., cancer immunotherapy), diagnostics (NGS-based tests), medical devices (robotics/stents), and digital health platforms. The team provides hands-on support for R&D strategy and business development to its investees.

Therapeutic areas: OncologyPulmonologyEndocrinologyImmunologyNeurology
Modalities: AntibodymRNA-based drugsSmall moleculeBiologic
Industry: Investors

Partnerships

Invested alongside Proxima Ventures in Bioelectronica Corporation for single-cell sorting technology developmentFrequently co-invests with Matrix Partners ChinaFrequently co-invests with SBCVC

Beyond the preview

Go deeper on Co-win Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Co-win Ventures.

Explore the full profile